Unresectable Myxofibrosarcoma
1 clinical trials · Condition
◉ Watch Unresectable Myxofibrosarcoma
| Record | Firm | Date |
|---|---|---|
| Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma (NCT05711615) | National Cancer Institute (NCI) | 2024-02-06 |
Track Unresectable Myxofibrosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.